Login / Signup

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Ji Hyun LeeSeong Gu HeoBeung-Chul AhnMin Hee HongByoung Chul ChoSun Min LimHye Ryun Kim
Published in: Cancer medicine (2021)
NCT02216916.
Keyphrases
  • phase ii study
  • squamous cell carcinoma
  • locally advanced
  • open label
  • small cell lung cancer
  • placebo controlled
  • clinical trial
  • randomized controlled trial
  • radiation therapy